[Multiple sclerosis. Therapeutic nihilism is the wrong approach here]
[Article in
German]
Affiliations
- PMID: 12070851
Item in Clipboard
[Multiple sclerosis. Therapeutic nihilism is the wrong approach here]
[Article in
German]
MMW Fortschr Med.
.
Abstract
The standard treatment for acute multiple sclerosis relapses continues to be the intravenous administration of high-dose methylprednisolone. For prophylactic purposes, immunomodulatory therapy with interferon beta or glatiramer acetate, immunoglobulins or azathioprine. Studies have shown that interferon beta not only reduces the frequency of relapses by one-third, but also significantly delays the second relapse, provided it is administrated early, that is, immediately following the first relapse. The reduction in the patient's quality of life caused by the illness can be appreciably improved by a whole series of symptomatic treatments. The ideal situation is a cooperative effort by an interdisciplinary team.
Similar articles
-
[New immunomodulator for multiple sclerosis patients. 30% fewer relapse rates].MMW Fortschr Med. 2002 May 6;Suppl 2:88. MMW Fortschr Med. 2002. PMID: 12070870 German. No abstract available.
-
[Treatment of progressive forms of multiple sclerosis].Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):1008-13. Rev Neurol (Paris). 2001. PMID: 11787331 French.
-
[Immunomodulatory therapy in multiple sclerosis].Ideggyogy Sz. 2004 Nov 20;57(11-12):401-16. Ideggyogy Sz. 2004. PMID: 15662768 Review. Hungarian.
-
[Treatment of remitting forms of multiple sclerosis].Rev Neurol (Paris). 2001 Sep;157(8-9 Pt 2):996-1000. Rev Neurol (Paris). 2001. PMID: 11787366 French.
-
Current disease-modifying therapies in multiple sclerosis.Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138. Semin Neurol. 2003. PMID: 12894379 Review.